Impact of functional IL-18 polymorphisms on genetic predisposition and diverse clinical manifestations of the disease in Indian SLE patients

Abstract

Several studies have demonstrated associations between interleukin-18 polymorphisms and risk of systemic lupus erythematosus in different populations except one of Indian origin. We therefore investigated for the influence of interleukin-18 (-1297T/C, -607A/C, -137G/C; + 105A/C) polymorphisms on genetic susceptibility and clinical expression of the disease in Indian systemic lupus erythematosus patients. A total of 200 systemic lupus erythematosus patients and 201 controls were recruited. Genotyping of interleukin-18 polymorphisms were performed by polymerase chain reaction-restriction fragment length polymorphism. Serum interleukin-18 levels were measured by enzyme-linked immunosorbent assay. Interleukin-18 (-1297T/C; -137G/C) polymorphisms showed significant association with genetic susceptibility to the disease in our systemic lupus erythematosus cohort. Stratification analysis revealed -1297CC and -1297C associated with renal involvement (odds ratio = 3.4, correcting p value = 0.0207), (odds ratio = 2.0, correcting p value = 0.0054) respectively. Additionally, -1297C allele frequency was significantly increased in patients with anti-nucleosome antibody (odds ratio = 2.1, correcting p value = 0.0301). Haplotype analysis showed CC haplotype strongly associated with serositis (odds ratio = 9.1, correcting p values = 0.0009) and neurologic involvement (odds ratio = 9.3, correcting p value = 0.0018). We reported a 2.7-fold increase in serum interleukin-18 levels in patients (511.5 ± 242.3 pg/ml) compared to controls (189.4 ± 80.8 pg/ml) (p < 0.0001). Furthermore, interleukin-18 levels were positively correlated with disease activity (r = 0.548, p = 0.0001) and renal involvement in the patients with lupus nephritis (r = 0.569, p < 0.0001). In summary, interleukin-18 polymorphisms elucidated in this study appear to confer genetic susceptibility to the disease and are associated with renal, serositis and neurologic involvement in Indian systemic lupus erythematosus patients.

Keywords

Interleukin-18 polymorphisms Indian systemic lupus erythematosus pro-inflammatory cytokines

Get full access to this article

View all access options for this article.

References

Rahman

Isenberg

. Mechanism of disease systemic lupus erythematosus. N Engl J Med 2008; 358: 929–939.

Guarnizo-Zuccardi

Lopez

Giraldo

et al.

Cytokine gene polymorphisms in Colombian patients with systemic lupus erythematosus. Tissue Antigens 2007; 70(5): 376–382.

Chen

Jiang

Ren

Liu

Meng

. Association of IL-18 polymorphisms with rheumatoid arthritis and systemic lupus erythematosus in Asian populations: A meta-analysis. BMC Med Genet 2012; 15(13): 107.

Tominaga

Yoshimoto

Torigoe

et al.

IL-12 synergizes with IL-18 or IL-1beta for IFN-gamma production from human T cells. Int Immunol 2000; 12: 151–160.

Esfandiari

McInnes

Lindop

et al.

A proinflammatory role of IL-18 in the development of spontaneous autoimmune disease. J Immunol 2001; 167: 5338–5347.

Warchol

Lianeri

Wudarski

et al.

IL-18 105 A>C polymorphism contributes to renal manifestations in patients with SLE. Rheumatol Int 2009; 30: 187–191.

Hirankarn

Tangwattanachuleeporn

Wongpiyabovorn

et al.

Association of IL-18 gene polymorphism (-137C) with arthritis manifestations in SLE: Combined effect with IFN gamma gene polymorphism (+874A). Clin Rheumatol 2009; 28: 219–223.

Tin

Sivalingam

et al.

Interleukin-18promoter gene polymorphisms in Chinese patients with systemic lupus erythematosus: Association with CC genotype at position -607. Ann Acad Med Singapore 2007; 36(2): 91–95.

Hochberg

M.C

. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.

10.

Ausubel F, Brent R, Kingston R, et al. Short Protocols in Molecular Biology 1995; 3rd ed; Unit 2.1: 2–3.

11.

Warchoł

Lianeri

Olesińska

Jagodziński

. Interleukin-18 promoter polymorphisms in patients with systemic lupus erythematosus. Clin Exp Rheumatol 2011; 29(2): 310–313.

12.

Liu

. Functional IL-18 promoter gene polymorphisms and haplotypes in patients with lichen planus: A study in a Chinese population. African J Pharmacy Pharmacol 2012; 6(10): 751–755.

13.

Thio

Kirk

Donfield

Goedert

Winkler

. Regulatory polymorphisms in the interleukin-18 promoter are associated with hepatitis C virus clearance. J Infect Dis 2008; 198(8): 1159–1165.

14.

Lin

Wan

Lee

et al.

Disease association of the interleukin-18 promoter polymorphisms in Taiwan Chinese systemic lupus erythematosus patients. Genes Immun 2007; 8: 302–307.

15.

Bombardier

Gladman

Urowitz

et al.

Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35: 630–640.

16.

Gurram

Polipalli

Karra

et al.

Genetic polymorphism of interleukin-18 gene promoter region in rheumatoid arthritis patients from southern India. J Clin Diagn Res 2014; 8(6): SC01–4.

17.

Kretowski

Mironczuk

Karpinska

et al.

Interleukin-18 promoter polymorphisms in type 1 diabetes. Diabetes 2002; 51(11): 3347–3349.

18.

Karakas Celik

Öz

Dursun

et al.

Interleukin 18 gene polymorphism is a risk factor for multiple sclerosis. Mol Biol Rep 2014; 41(3): 1653–1658.

19.

Song

Choi

Lee

. Association between interleukin-18 polymorphisms and systemic lupus erythematosus: A meta-analysis. Mol Biol Rep 2013; 40(3): 2581–2587.

20.

Sánchez

Palomino-Morales

Ortego-Centeno

et al.

Identification of a new putative functional IL18 gene variant through an association study in systemic lupus erythematosus. Hum Mol Genet 2009; 1; 18(19): 3739–3748.

21.

Lan

Wei

Tang

et al.

Association of interleukin-18 gene polymorphism with genetic susceptibility to systematic lupus erythematosus in Guangxi Zhuang population. Zhonghua Yi Xue Yi Chuan Xue ZaZhi 2008; 25(4): 434–437.

22.

Warchoł

Lianeri

Wudarski

et al.

IL-18 105 A>C polymorphism contributes to renal manifestations in patients with SLE. Rheumatol Int 2009; 30(2): 187–191.

23.

Lin

Wan

Sheu

et al.

A/C polymorphism in the interleukin-18 coding region among Taiwanese systemic lupus erythematosus patients. Lupus 2008; 17(2): 124–127.

24.

Muller

Dieker

Tincani

Meroni

. Pathogenic anti-nucleosome antibodies. Lupus 2008; 17(5): 431–436.

25.

Ogata

Kitano

Fukamizu

et al.

Increased serum interleukin-18 in a patient with systemic lupus erythematosus and T-cell large granular lymphocytic leukemia. Mod Rheumatol 2004; 14: 267–270.

26.

Haus-Seuffert

Meisterernst

. Mechanisms of transcriptional activation of cAMP-responsive element-binding protein CREB. Mol Cell Biochem 2000; 212: 5–9.

27.

Dailey

Roberts

Heintz

. Purification of the human histone H4 gene-specific transcription factors H4TF-1 and H4TF-2. Genes Dev 1988; 2(12B): 1700–1712.

28.

Jafari-Nakhjavani

Abedi-Azar

Nejati

. Correlation of plasma interleukin-18 concentration and severity of renal involvement and disease activity in systemic lupus erythematosus. J Nephropathol 2016; 5(1): 28–33.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.14 MB